Chart: Biotech Stocks - Normalized Net Income Per Employee

Rob Zenilman submits: Normalized net income (includes the effect of taxes, but excludes any unusual items) per employee in the Biotech sector for the most recently reported fiscal year ranged from $383,617.40 (GILD) down to ($597,181.20) (ONXX), with a median value of $709.50

* View More Biotech Sector Charts *
Data in table version -- click on a ticker for opinion and analysis of the company:

			FY		Net
		FY	Net	# of	Per Employee
Ticker	Company	Ending	($mm)	Employees	($000)
AFFX	Affymetrix Inc.	12/31/05	$45.54	1,101
$41.36
ALXN	Alexion Pharmaceutic	12/31/05	-$80.70	241
-$334.84
AMGN	Amgen Inc.	12/31/05	$3,102.50	16,450
$188.60
AMLN	Amylin Pharmaceutica	12/31/05	-$129.27	1,150
-$112.41
BIIB	Biogen Idec Inc.	12/31/05	$331.33	3,340
$99.20
BMRN	BioMarin Pharmaceuti	12/31/05	-$45.73	314
-$145.64
BSTE	Biosite Incorporated	12/31/05	$55.21	1,003
$55.05
CELG	Celgene Corporation	12/31/05	$60.03	944
$63.59
DNA	Genentech Inc.	12/31/05	$1,294.76	9,500
$136.29
ELN	Elan Corp. plc	12/31/05	-$273.50	1,729
-$158.18
GILD	Gilead Sciences Inc.	12/31/05	$728.87	1,900
$383.62
GPRO	Gen-Probe Inc.	12/31/05	$57.31	866
$66.18
IMCL	Imclone Systems Inc.	12/31/05	$60.92	991
$61.48
INCY	Incyte Corp.	12/31/05	-$65.81	177
-$371.82
ISTA	ISTA Pharmaceuticals	12/31/05	-$24.05	161
-$149.38
KOSP	KOS Pharmaceuticals	12/31/05	$119.63	1,361
$87.90
MEDI	MedImmune Inc.	12/31/05	$52.50	2,059
$25.50
NABI	Nabi Biopharmaceutic	12/31/05	-$61.41	776
-$79.13
NBIX	Neurocrine Bioscienc	12/31/05	-$13.87	576
-$24.08
ONXX	Onyx Pharmaceuticals	12/31/05	-$59.72	100
-$597.18
PGNX	Progenics Pharmaceut	12/31/05	-$43.27	149
-$290.39
PHRM	Pharmion Corp.	12/31/05	$20.19	328
$61.56
TELK	Telik Inc.	12/31/05	-$47.21	162
-$291.44
VRTX	Vertex Pharmaceutica	12/31/05	-$91.92	810
-$113.48

Data: CapitalIQ

Related:

1. Most recent opinion and analysis of Biotech stocks
2. Full transcripts of recent conference calls in the Biotech sector
3. Add the Biotech Stock Blog to your My Yahoo! page

Aside: Did you know that Seeking Alpha now publishes a daily recap of Jim Cramer's Mad Money stock picks?